Acute Ischemia of Lower Limb Clinical Trial
Official title:
Treatment of Acute Lower Limb Ischaemia in Sweden 1994-2014
Study of acute lower ischemia therapies based on data collected from the Swedish Vascular
Surgery Registry between 1994 and 2014.
Primary endpoint is long term amputation-free survival and secondary end-points are 30 days
and 1 year amputation-free survival as well as different revascularization techniques
results and time trends.
The prospective Swedish Vascular Registry (Swedvasc) started in 1987 and since 1994 it has
included more than 95 percent of the vascular surgical procedures performed nationwide. The
registry has received extensive high internal and external validation. Roughly 16000 open
surgical and endovascular revascularisation procedures for acute limb ischemia have been
performed during this period of time.
The fact that every Swedish citizen has a unique personal identification number makes it
possible to obtain 100 percent accurate survival and amputation data. Survival data were
obtained through crosschecking the personal identification number with the national
population registry in June 2016.
This offers a unique opportunity to study a large population-based cohort of unselected
patients.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03386370 -
The Indigo System in Acute Lower Limb Malperfusion
|
N/A | |
Recruiting |
NCT05255640 -
OUTCOME OF PATIENTS ADMITTED WITH ACUTE LOWER EXTREMITY ISCHEMIA
|